Justice Department Moves Limited Marijuana Products to Schedule III, Sets Fast-Track Hearing on Broader Rescheduling
DOJ on April 23 moved FDA‑approved and state‑licensed medical marijuana products to Schedule III and opened a fast‑track hearing on broader rescheduling starting June 29, 2026.